5-Methyltetrahydrofolate Attenuates Oxidative Stress and Improves Kidney Function in Acute Kidney Injury Through Activation of Nrf2 and Antioxidant Defense

Overview

Journal Antioxidants (Basel)

Date 2022 Jun 24

PMID 35739943

Authors

Charith U B Wijerathne

Kathy K W Au-Yeung

Yaw L Siow

Karmin O

Affiliations

Soon will be listed here.

Abstract

Oxidative stress is a major mediator of adverse outcomes in acute kidney injury (AKI). Deficiency of micronutrients, such as folate, is common in AKI. Our previous study reported that AKI impaired kidney reabsorption of folate and decreased plasma folate level in rats. The present study investigated the effect of 5-methyltetrahydrofolate (5-MTHF), a biologically active form of folate/folic acid, on AKI-impaired kidney function and oxidative stress. Sprague-Dawley rats developed AKI after kidney ischemia (45 min) and reperfusion (24 h). Injection of 5-MTHF (3 µg/kg body weight) improved kidney function and attenuated oxidative stress with a restoration of glutathione and a reduction of lipid peroxidation in the kidney. Injection of 5-MTHF activated transcription factor Nrf2 and increased the expression of glutathione synthesizing enzymes, superoxide dismutase-1 and heme oxygenase-1 in the kidney. Simulated ischemia-reperfusion through hypoxia-reoxygenation increased oxidative stress in proximal tubular cells. Incubation of cells with 5-MTHF alleviated cell injury and increased antioxidant enzyme expression and intracellular glutathione levels. Inhibition of Nrf2 expression through siRNA transfection abolished the effect of 5-MTHF against oxidative stress. These results suggest that low-dose folic acid can improve kidney function through activation of Nrf2 and restoration of antioxidant defence. Micronutrient supplements may improve clinical outcomes in AKI.

Citing Articles

The association of metabolic profile of folate with diabetic kidney disease: evidence from 2011-2020 cycles of the NHANES.

Liang Y, Ding L, Tao M, Zhu Y Ren Fail. 2024; 46(2):2420830.

PMID: 39477815 PMC: 11533242. DOI: 10.1080/0886022X.2024.2420830.

Unveiling the Therapeutic Potential of Folate-Dependent One-Carbon Metabolism in Cancer and Neurodegeneration.

Sobral A, Cunha A, Silva V, Gil-Martins E, Silva R, Barbosa D Int J Mol Sci. 2024; 25(17).

PMID: 39273288 PMC: 11395277. DOI: 10.3390/ijms25179339.

The Significance of Genetically Determined Methylation and Folate Metabolism Disorders in the Pathogenesis of Coronary Artery Disease: A Target for New Therapies?.

Pietruszynska-Reszetarska A, Pietruszynski R, Irzmanski R Int J Mol Sci. 2024; 25(13).

PMID: 39000032 PMC: 11241586. DOI: 10.3390/ijms25136924.

Neutrophils and NADPH Oxidases Are Major Contributors to Mild but Not Severe Ischemic Acute Kidney Injury in Mice.

Revesz C, Kaucsar T, Godo M, Bocskai K, Krenacs T, Mocsai A Int J Mol Sci. 2024; 25(5).

PMID: 38474193 PMC: 10932292. DOI: 10.3390/ijms25052948.

Associations between Serum Folate Concentrations and Functional Disability in Older Adults.

Ji L, Zhang T, Zhang L, Zhang D Antioxidants (Basel). 2023; 12(3).

PMID: 36978867 PMC: 10045063. DOI: 10.3390/antiox12030619.

References

Cao P, Zhang W, Wang G, Zhao X, Gao N, Liu Z . Low Dose of Folic Acid Can Ameliorate Hyperhomocysteinemia-Induced Cardiac Fibrosis and Diastolic Dysfunction in Spontaneously Hypertensive Rats. Int Heart J. 2021; 62(3):627-635. DOI: 10.1536/ihj.20-593. View

Woo C, Prathapasinghe G, Siow Y, O K . Hyperhomocysteinemia induces liver injury in rat: Protective effect of folic acid supplementation. Biochim Biophys Acta. 2006; 1762(7):656-65. DOI: 10.1016/j.bbadis.2006.05.012. View

Wu N, Siow Y, O K . Ischemia/reperfusion reduces transcription factor Sp1-mediated cystathionine beta-synthase expression in the kidney. J Biol Chem. 2010; 285(24):18225-33. PMC: 2881747. DOI: 10.1074/jbc.M110.132142. View

Liu M, Grigoryev D, Crow M, Haas M, Yamamoto M, Reddy S . Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int. 2009; 76(3):277-85. DOI: 10.1038/ki.2009.157. View

Hamatani R, Otsu M, Chikamoto H, Akioka Y, Hattori M . Plasma homocysteine and folate levels and dietary folate intake in adolescents and young adults who underwent kidney transplantation during childhood. Clin Exp Nephrol. 2013; 18(1):151-6. DOI: 10.1007/s10157-013-0819-3. View

Ratliff B, Abdulmahdi W, Pawar R, Wolin M . Oxidant Mechanisms in Renal Injury and Disease. Antioxid Redox Signal. 2016; 25(3):119-46. PMC: 4948213. DOI: 10.1089/ars.2016.6665. View

Damaraju V, Cass C, Sawyer M . Renal conservation of folates role of folate transport proteins. Vitam Horm. 2008; 79:185-202. DOI: 10.1016/S0083-6729(08)00406-8. View

Forman H, Zhang H . Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021; 20(9):689-709. PMC: 8243062. DOI: 10.1038/s41573-021-00233-1. View

Sid V, Siow Y, O K . Role of folate in nonalcoholic fatty liver disease. Can J Physiol Pharmacol. 2017; 95(10):1141-1148. DOI: 10.1139/cjpp-2016-0681. View

10.

Lameire N, Van Biesen W, Vanholder R . Acute renal failure. Lancet. 2005; 365(9457):417-30. DOI: 10.1016/S0140-6736(05)17831-3. View

11.

Dai X, Yan X, Wintergerst K, Cai L, Keller B, Tan Y . Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function. Trends Mol Med. 2019; 26(2):185-200. DOI: 10.1016/j.molmed.2019.09.007. View

12.

Boekhoud L, Koeze J, van der Slikke E, Bourgonje A, Moser J, Zijlstra J . Acute Kidney Injury is Associated with Lowered Plasma-Free Thiol Levels. Antioxidants (Basel). 2020; 9(11). PMC: 7696918. DOI: 10.3390/antiox9111135. View

13.

Griffith O . Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med. 1999; 27(9-10):922-35. DOI: 10.1016/s0891-5849(99)00176-8. View

14.

Wijerathne C, Madduma Hewage S, Siow Y, O K . Kidney Ischemia-Reperfusion Decreases Hydrogen Sulfide and Increases Oxidative Stress in the Heart. Biomolecules. 2020; 10(11). PMC: 7698428. DOI: 10.3390/biom10111565. View

15.

Wu M, Yiang G, Liao W, Tsai A, Cheng Y, Cheng P . Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell Physiol Biochem. 2018; 46(4):1650-1667. DOI: 10.1159/000489241. View

16.

Jo S, Rosner M, Okusa M . Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol. 2007; 2(2):356-65. DOI: 10.2215/CJN.03280906. View

17.

Mutavdzin S, Gopcevic K, Stankovic S, Uzelac J, Labudovic Borovic M, Djuric D . The Effects of Folic Acid Administration on Cardiac Oxidative Stress and Cardiovascular Biomarkers in Diabetic Rats. Oxid Med Cell Longev. 2019; 2019:1342549. PMC: 6594301. DOI: 10.1155/2019/1342549. View

18.

Hwang S, Siow Y, Au-Yeung K, House J, O K . Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney. Am J Physiol Renal Physiol. 2010; 300(1):F189-98. DOI: 10.1152/ajprenal.00272.2010. View

19.

Shang Y, Siow Y, Isaak C, O K . Downregulation of Glutathione Biosynthesis Contributes to Oxidative Stress and Liver Dysfunction in Acute Kidney Injury. Oxid Med Cell Longev. 2016; 2016:9707292. PMC: 5107229. DOI: 10.1155/2016/9707292. View

20.

Yan L . Folic acid-induced animal model of kidney disease. Animal Model Exp Med. 2022; 4(4):329-342. PMC: 8690981. DOI: 10.1002/ame2.12194. View